Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy

Cancer is one of the leading causes of death in the world. A cancer-targeted multifunctional probe labeled with the radionuclide has been developed to provide multi-modalities for NIR fluorescence and nuclear imaging (PET, SPECT), for photothermal therapy (PTT), and targeted radionuclide therapy of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheng-Liang Peng, Ying-Hsia Shih, Ping-Fang Chiang, Chun-Tang Chen, Ming-Cheng Chang
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b2655319a20f405a9404407765cc919f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b2655319a20f405a9404407765cc919f
record_format dspace
spelling oai:doaj.org-article:b2655319a20f405a9404407765cc919f2021-11-25T17:54:23ZMultifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy10.3390/ijms2222122141422-00671661-6596https://doaj.org/article/b2655319a20f405a9404407765cc919f2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12214https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Cancer is one of the leading causes of death in the world. A cancer-targeted multifunctional probe labeled with the radionuclide has been developed to provide multi-modalities for NIR fluorescence and nuclear imaging (PET, SPECT), for photothermal therapy (PTT), and targeted radionuclide therapy of cancer. In this study, synthesis, characterization, in vitro, and in vivo biological evaluation of the cyanine-based probe (DOTA-NIR790) were demonstrated. The use of cyanine dyes for the selective accumulation of cancer cells were used to achieve the characteristics of tumor markers. Therefore, all kinds of organ tumors can be targeted for diagnosis and treatment. The DOTA-NIR790 labeled with lutetium-111 could detect original or metastatic tumors by using SPECT imaging and quantify tumor accumulation. The β-emission of <sup>177</sup>Lu-DOTA-NIR790 can be used for targeted radionuclide therapy of tumors. The DOTA-NIR790 enabled imaging by NIR fluorescence and by nuclear imaging (SPECT) to monitor in real-time the tumor accumulation and the situation of cancer therapy, and to guide the surgery or the photothermal therapy of the tumor. The radionuclide-labeled heptamethine cyanine based probe (DOTA-NIR790) offers multifunctional modalities for imaging and therapies of cancer.Cheng-Liang PengYing-Hsia ShihPing-Fang ChiangChun-Tang ChenMing-Cheng ChangMDPI AGarticlemulti-modalitycyanine dyenear-infrared fluorescence imagingnuclear imagingphotothermal therapytargeted radionuclide therapyBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12214, p 12214 (2021)
institution DOAJ
collection DOAJ
language EN
topic multi-modality
cyanine dye
near-infrared fluorescence imaging
nuclear imaging
photothermal therapy
targeted radionuclide therapy
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle multi-modality
cyanine dye
near-infrared fluorescence imaging
nuclear imaging
photothermal therapy
targeted radionuclide therapy
Biology (General)
QH301-705.5
Chemistry
QD1-999
Cheng-Liang Peng
Ying-Hsia Shih
Ping-Fang Chiang
Chun-Tang Chen
Ming-Cheng Chang
Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy
description Cancer is one of the leading causes of death in the world. A cancer-targeted multifunctional probe labeled with the radionuclide has been developed to provide multi-modalities for NIR fluorescence and nuclear imaging (PET, SPECT), for photothermal therapy (PTT), and targeted radionuclide therapy of cancer. In this study, synthesis, characterization, in vitro, and in vivo biological evaluation of the cyanine-based probe (DOTA-NIR790) were demonstrated. The use of cyanine dyes for the selective accumulation of cancer cells were used to achieve the characteristics of tumor markers. Therefore, all kinds of organ tumors can be targeted for diagnosis and treatment. The DOTA-NIR790 labeled with lutetium-111 could detect original or metastatic tumors by using SPECT imaging and quantify tumor accumulation. The β-emission of <sup>177</sup>Lu-DOTA-NIR790 can be used for targeted radionuclide therapy of tumors. The DOTA-NIR790 enabled imaging by NIR fluorescence and by nuclear imaging (SPECT) to monitor in real-time the tumor accumulation and the situation of cancer therapy, and to guide the surgery or the photothermal therapy of the tumor. The radionuclide-labeled heptamethine cyanine based probe (DOTA-NIR790) offers multifunctional modalities for imaging and therapies of cancer.
format article
author Cheng-Liang Peng
Ying-Hsia Shih
Ping-Fang Chiang
Chun-Tang Chen
Ming-Cheng Chang
author_facet Cheng-Liang Peng
Ying-Hsia Shih
Ping-Fang Chiang
Chun-Tang Chen
Ming-Cheng Chang
author_sort Cheng-Liang Peng
title Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy
title_short Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy
title_full Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy
title_fullStr Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy
title_full_unstemmed Multifunctional Cyanine-Based Theranostic Probe for Cancer Imaging and Therapy
title_sort multifunctional cyanine-based theranostic probe for cancer imaging and therapy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b2655319a20f405a9404407765cc919f
work_keys_str_mv AT chengliangpeng multifunctionalcyaninebasedtheranosticprobeforcancerimagingandtherapy
AT yinghsiashih multifunctionalcyaninebasedtheranosticprobeforcancerimagingandtherapy
AT pingfangchiang multifunctionalcyaninebasedtheranosticprobeforcancerimagingandtherapy
AT chuntangchen multifunctionalcyaninebasedtheranosticprobeforcancerimagingandtherapy
AT mingchengchang multifunctionalcyaninebasedtheranosticprobeforcancerimagingandtherapy
_version_ 1718411881270476800